Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Acquisitions & Divestments: 2014-2024

Historic Change in Acquisitions & Divestments for Neurogene (NGNE) over the last 7 years, with Dec 2024 value amounting to $74.0 million.

  • Neurogene's Change in Acquisitions & Divestments rose 1037.14% to $99.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.9 million, marking a year-over-year increase of 260.40%. This contributed to the annual value of $74.0 million for FY2024, which is 1380.00% up from last year.
  • Per Neurogene's latest filing, its Change in Acquisitions & Divestments stood at $74.0 million for FY2024, which was up 1,380.00% from $5.0 million recorded in FY2023.
  • Neurogene's Change in Acquisitions & Divestments' 5-year high stood at $74.0 million during FY2024, with a 5-year trough of $5.0 million in FY2023.
  • Its 2-year average for Change in Acquisitions & Divestments is $39.5 million, with a median of $39.5 million in 2023.
  • Data for Neurogene's Change in Acquisitions & Divestments shows a peak YoY surged of 1,380.00% (in 2024) over the last 5 years.
  • Neurogene's Change in Acquisitions & Divestments (Yearly) stood at $5.0 million in 2023, then surged by 1,380.00% to $74.0 million in 2024.